Climate change and cascading risks from infectious disease

JC Semenza, J Rocklöv, KL Ebi - Infectious diseases and therapy, 2022 - Springer
Climate change is adversely affecting the burden of infectious disease throughout the world,
which is a health security threat. Climate-sensitive infectious disease includes vector-borne …

Emerging concepts and technologies in vaccine development

M Brisse, SM Vrba, N Kirk, Y Liang, H Ly - Frontiers in immunology, 2020 - frontiersin.org
Despite the success of vaccination to greatly mitigate or eliminate threat of diseases caused
by pathogens, there are still known diseases and emerging pathogens for which the …

RTS, S/AS01 vaccine (Mosquirix™): an overview

MB Laurens - Human vaccines & immunotherapeutics, 2020 - Taylor & Francis
Malaria is an illness caused by Plasmodium parasites transmitted to humans by infected
mosquitoes. Of the five species that infect humans, P. falciparum exacts the highest toll in …

Vaccine adjuvants: from 1920 to 2015 and beyond

A Di Pasquale, S Preiss, F Tavares Da Silva, N Garçon - Vaccines, 2015 - mdpi.com
The concept of stimulating the body's immune response is the basis underlying vaccination.
Vaccines act by initiating the innate immune response and activating antigen presenting …

Seven-year efficacy of RTS, S/AS01 malaria vaccine among young African children

A Olotu, G Fegan, J Wambua… - … England Journal of …, 2016 - Mass Medical Soc
Background The candidate malaria vaccine RTS, S/AS01 is being evaluated in order to
inform a decision regarding its inclusion in routine vaccination schedules. Methods We …

Genetic diversity and protective efficacy of the RTS, S/AS01 malaria vaccine

DE Neafsey, M Juraska, T Bedford… - … England Journal of …, 2015 - Mass Medical Soc
Background The RTS, S/AS01 vaccine targets the circumsporozoite protein of Plasmodium
falciparum and has partial protective efficacy against clinical and severe malaria disease in …

Beyond antigens and adjuvants: formulating future vaccines

TJ Moyer, AC Zmolek, DJ Irvine - The Journal of clinical …, 2016 - Am Soc Clin Investig
The need to optimize vaccine potency while minimizing toxicity in healthy recipients has
motivated studies of the formulation of vaccines to control how, when, and where antigens …

Childhood adiposity, adult adiposity, and cardiovascular risk factors

M Juonala, CG Magnussen, GS Berenson… - … England Journal of …, 2011 - Mass Medical Soc
Background Obesity in childhood is associated with increased cardiovascular risk. It is
uncertain whether this risk is attenuated in persons who are overweight or obese as children …

Vaccines for the 21st century

I Delany, R Rappuoli, E De Gregorio - EMBO molecular medicine, 2014 - embopress.org
In the last century, vaccination has been the most effective medical intervention to reduce
death and morbidity caused by infectious diseases. It is believed that vaccines save at least …

Systems analysis of protective immune responses to RTS, S malaria vaccination in humans

D Kazmin, HI Nakaya, EK Lee… - Proceedings of the …, 2017 - National Acad Sciences
RTS, S is an advanced malaria vaccine candidate and confers significant protection against
Plasmodium falciparum infection in humans. Little is known about the molecular …